Martin J. Murphy, DMedSc, PhD, FASCO co-chairs the Scientific & Strategic Advisory Council of the International Alliance for COVID-19 Data Research (ICODA).

Dr. Murphy was Founding CEO and Board Director of the 20-year-old non-profit CEO Roundtable on Cancer at the request of the late 41st President George H.W. Bush. Marty was also Founding CEO of Project Data Sphere® (PDS), a non-profit initiative of the CEO Roundtable devoted to cancer clinical trial data-sharing and analysis. He is Chief Executive Officer of the non-profit Shanghai TuoXin Health Promotion Center that has expanded its purview to include international COVID-19 interventions and global pandemic preparedness.

Founding Executive Editor of the 25-year-old peer-reviewed journal, The Oncologist, Dr. Murphy is also Founding Editor of “Stem Cells”, the 38-year-old flagship journal of stem cell biology, Co-Founder of its 9 year-old sister journal, “Stem Cells Translational Medicine” reporting on stem cells in clinical trials, and the 25 year-old cancer medicine journal, “The Oncologist”. An NIH principal investigator, he has authored more than 180 primary peer-accepted papers and 7 books, is co-founder of Society for Translational Oncology, member of six Scientific Advisory Boards, Chairman Emeritus of Conquer Cancer—ASCO Foundation, and Steering Member of Chinese Society of Clinical Oncology. He is a member of National Cancer Policy Forum of National Academy of Medicine (US National Academy of Sciences), member of Center for Public Health Advisory Board, Milken Institute, is emeritus director of Foundation for NIH, Fellow of American Society of Clinical Oncology, and former vice chairman of C-Change. He is married to Ann Murphy, PhD, president and founder of AlphaMed Press and co-founder and executive director of Society for Translational Oncology. They have five adult children and ten grandchildren.